Two Sigma Advisers’s Cyclerion Therapeutics CYCN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-900
| Closed | -$7.81K | – | 2439 |
|
|
2023
Q1 | $7.81K | Sell |
900
-290
| -24% | -$2.52K | ﹤0.01% | 2555 |
|
|
2022
Q4 | $15.6K | Sell |
1,190
-640
| -35% | -$8.4K | ﹤0.01% | 2443 |
|
|
2022
Q3 | $31K | Sell |
1,830
-3,005
| -62% | -$50.9K | ﹤0.01% | 2414 |
|
|
2022
Q2 | $53K | Sell |
4,835
-5,920
| -55% | -$64.9K | ﹤0.01% | 2471 |
|
|
2022
Q1 | $239K | Sell |
10,755
-15,315
| -59% | -$340K | ﹤0.01% | 2324 |
|
|
2021
Q4 | $897K | Sell |
26,070
-6,315
| -19% | -$217K | ﹤0.01% | 1616 |
|
|
2021
Q3 | $1.99M | Buy |
32,385
+16,060
| +98% | +$986K | 0.01% | 1259 |
|
|
2021
Q2 | $1.27M | Buy |
16,325
+7,835
| +92% | +$611K | ﹤0.01% | 1526 |
|
|
2021
Q1 | $474K | Buy |
8,490
+5,660
| +200% | +$316K | ﹤0.01% | 2033 |
|
|
2020
Q4 | $173K | Buy |
+2,830
| New | +$173K | ﹤0.01% | 2201 |
|